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A Forty-Year Perspective 
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It is widely known that medical costs have increased over time. In the United 
States, as in most of  the developed world, medical spending growth has ex- 
ceeded income growth by several percentage points per year for three decades 
or longer (Levit et al. 1994). In country after country, the cost of medical care 
has become a major public sector issue. 
But much less is known about what medical spending is buying us. Is medi- 
cal spending valuable or wasteful? Should we want to limit total spending or 
increase it? The answer to this question is by no means clear. On the one hand 
is voluminous evidence that medical spending conveys great value. Random- 
ized clinical trials, for example, routinely document the benefits of new phar- 
maceuticals  and medical devices. And we would venture to guess that most 
people would prefer today's medical system to the medical system of 30 years 
ago, even given the much higher cost of medical care today. This suggests that 
people are on net better  off with the additional medical care spending than 
they would be without it. 
On the other hand is a great sense that medical care often brings little in the 
way of health benefit. Nearly one-third of Medicare spending occurs in the last 
six months of life (Lubitz and Riley 1993), which has been interpreted as evi- 
dence that a lot of  medical care is wasted on those who will not in any case 
survive.'  Other  studies,  such  as the  RAND Health  Insurance  Experiment 
(Newhouse et al.  1992), show that putting people in less generous insurance 
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1.  Of  course, since people who are sick are more likely to die than people who are healthy, 
medical care spending will naturally be skewed to those near death. Still, the magnitude of the 
skewness is large. 
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policies reduces their spending on medical services but does not affect their 
health. And direct estimates of the value of medical care typically find that, at 
the margin, a substantial amount of medical care has little or no health benefit 
(Chassin et al. 1987; Greenspan et al. 1988; Winslow et al. 1988a, 1988b; Kahn 
et al.  1990; Newhouse et al.  1992; Cutler  1995; Staiger and Gaumer  1994; 
McClellan and Newhouse 1995).’ 
Our goal is to understand why medical care has become so expensive over 
time and what has been its value to society. We focus particularly on medical 
spending by  age. Many  of  the concerns about the medical care system are 
associated with changes in the age distribution of  medical resources and an 
increase in the share of resources going to the elderly (Lubitz et al. 1995). And 
the most pressing cost problem in the medical care economy is the pending 
insolvency  of  trust  funds to  provide  medical care for the  elderly. Further, 
growth in spending by age is important in forecasting medical costs as society 
ages (Lubitz et al. 1995). If patterns of medical spending by age are changing 
over time, projections of spending based solely on the number of people of 
different ages will be inaccurate. 
Our analysis is based on periodic  surveys of national health expenditures 
conducted in 1953, 1963, 1970, 1977, and 1987. The surveys have large num- 
bers of people (from 8,000 to 40,000 people per survey) and aggregate all of 
acute care spending. 
Our analysis of age-based spending documents two conclusions. First, there 
has been a dramatic change in the distribution of medical spending over time. 
While spending on medical care has increased for all people, it has increased 
disproportionately  for the very young  (those under  1 year old) and the old 
(those 65 years old or older). Over the 24-year period from 1963 through 1987, 
per person spending on infants increased by 9.8 percent per year, and per per- 
son spending on the elderly increased by 8.0 percent per year, compared to a 
rise of only 4.7 percent per year for the “middle-aged” (1-64  years old). The 
share of medical care spending for infants and the elderly doubled from 17 to 
36 percent. 
We further show that essentially all of the disproportionate growth of spend- 
ing for the very young and the old is accounted for by high-cost users within 
those groups. For infants, 89 percent of the excess spending increase over the 
middle-aged is accounted for by the top 10 percent of the spending distribu- 
tion. For the elderly, the equivalent share is 66 percent. Thus, in understanding 
the concentration of medical spending by age, we need to understand the con- 
centration of spending among high-cost users. 
In section 4.3, we consider who are the high-cost users of medical care. We 
show that a substantial amount of high-cost medical use is associated with the 
2. Cutler and Staiger (1996) review the evidence on the marginal and average value of  medi- 
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increasing technological capability of medicine. Among infants, high-cost us- 
ers are premature babies with substantial respiratory or other acute conditions. 
For the elderly, high-cost users are generally patients with severe cardiovascu- 
lar problems or cancer. For both infants and the elderly, the capacity to devote 
many more resources to the most pressing cases has increased over time. 
In section 4.4, we look at how health outcomes for premature infants and 
the sick elderly have changed over time. We find substantial health improve- 
ments in most of the categories of high-cost  medical care. Infant mortality 
among very low birth weight infants has fallen substantially at exactly the time 
when the cost of these infants has risen most rapidly. And mortality improve- 
ments among the elderly have been  especially prominent  in cardiovascular 
care, where spending increases have been dramatic. Our analysis is not causal; 
we do not have any direct link between the technologies we discuss in section 
4.3 and the outcomes we analyze in section 4.4. But our results suggest such a 
link is plausible. 
We begin in the next section with some basic facts about the distribution of 
medical spending over time. In section 4.2, we look at the age distribution of 
medical care utilization. Section 4.3 focuses in more detail on high-cost users 
of medical care. Section 4.4 looks at trends in medical outcomes over time, 
Section 4.5 concludes. 
4.1  The Basics of Medical Spending 
Much of our knowledge about individual spending on medical services is 
based on periodic surveys of national medical expenditures that have been con- 
ducted over time. In the post-World  War I1 period, there have been seven such 
surveys: the  1953 and  1958 National Surveys of Family Medical Costs and 
Voluntary Health Insurance in the United States; the  1963 and 1970 Surveys 
of Health Services Utilization and Expenditures; the 1977 and 1980 National 
Medical  Care Utilization  and Expenditure Surveys; and the  1987 National 
Medical Expenditure Survey (NMES). Beginning with the 1963 survey, all of 
the surveys are available in machine-readable form; for data from the 1950s, 
we are forced to use published tabulations from the survey authors (Anderson, 
Collette, and Feldman 1963; Anderson and Feldman 1956). In the absence of 
microdata, we omit consideration of the 1958 survey. We also omit the 1980 
survey because we are interested in long-term trends, so differences between 
1977 and 1980 data are less important for this analysis. We would clearly like 
to have more recent data for our analysis; while there is a more recent survey 
being conducted (the 1996 NMES), these data are not yet available. 
The surveys all gather information on the range of acute care medical expen- 
ditures in a one-year period. Several features of the data are important to note. 
Newborn hospital admissions for delivery are counted as part the mother’s ad- 
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Table 4.1  Characteristics of Medical Spending 
Number of  Average 
Year  Observations  Spending* 
1953  8,846  278 
1963  7,803  385 
1970  11,619  668 
(43) 
1977  38,815  874 
(16) 





Share of Spending by Percentile (%) 
Change (%)  Below 50th  50th-90th  90th+ 
-  -  -  143b 
3.3  5  36  59 
7.9  4  30  66 
3.8  3  27  70 




Nore: Numbers in parentheses are standard errors. 
"Average spending is in real (1987) dollars adjusted using the GDP deflator. 
bAccording to Anderson and Feldman (1956). the top 11 percent of  the health spending distribution con- 
sumed 43 percent of  all health care dollars in  1953. Without microdata it is impossible to know exactly 
what share of medical spending the top 10 percent consumed. 
which case the newborn is recorded  as having a separate admi~sion.~  In all 
cases, the institutionalized population  is not included in the survey, and any 
information on long-term care is excluded. With the exception of  the  1987 
NMES long-term care supplement, the surveys give no information about nurs- 
ing home spending, including spending on nursing homes for those now living 
in the community. 
Table 4.1 shows summary statistics about the data. The sample sizes are 
large: 8,846 in  1953, 7,803 in  1963, 11,619 in  1970, 38,815 in  1977, and 
34,456 in 1987.  Table 4.1 also shows basic statistics about medical care spend- 
ing. In real (1987 dollar) terms, medical spending rose from $278 per person 
in  1953 to $1,521 per person in 1987. Growth was 3.3 percent per year in the 
1953-63  period. Growth was most rapid in the 1963-70  period (7.9 percent 
per year), when Medicare and Medicaid were created and insurance coverage 
for the privately insured population expanded as well. In the next seven years, 
growth slowed to 3.8 percent per year. In the 1980s, spending growth increased 
again, to 5.5 percent per year. The average change over the entire period is 5.0 
percent per year. 
The remaining columns of table 4.1 document another frequently noted fact 
about medical spending (Berk and Monheit 1992): medical spending has be- 
come more concentrated among high-cost users over time. In 1953, the top 10 
percent of  the spending distribution accounted for less than 43 percent of total 
spending; by  1987, that share was 72 percent. Most of the increase occurred in 
3. In the 1987 data, attempts were made to assign costs separately to newborns and mothers in 
all cases, but there are cost variables that assign the newborn's  costs to the mother for normal 
deliveries where the newborn's stay does not exceed that of  the mother. 219  The Medical Costs of the Young and Old: A Forty-Year Perspective 
the 1950s and 1960s; since 1970, the distribution of overall medical spending 
has been relatively stable. 
4.2  Medical Spending by Age 
While the aggregate facts about medical spending are well known, much 
less is known about the distribution of  medical spending by  age or disease. 
Ideally, we would construct a set of “national disease accounts”-accounts 
that measure spending on particular diseases over time.4  But the surveys do not 
include detailed diagnosis codes for spending prior to 1977. Instead, we con- 
sider first medical spending by age. 
We denote spending for age group a at time t by C,(a).  We divide the popula- 
tion  into  11 age groups: under  1, 1-4,  5-14,  15-24,  25-34,  35-44,  45-54, 
55-64,  65-74,  75-84,  and 85+.s Table 4A.1 in the appendix shows average 
spending for survey years between 1963 and 1987, as well as average annual 
growth rates within age groups. To examine differential spending by age over 
time, we define relative age-specific spending as 
c, (4 
c: (35-44)  .  c;(a)  = 
Figure 4.1A  shows relative medical spending by  age for each of  the five 
surveys. The data show a clear pattern: relative to spending on 35-44-year- 
olds, spending for the very young (those less than age 1) and the old (those 
above age 65) has increased dramatically over time. The trend for infants is 
startling. In 1953, per capita spending on those under age 5 was less than half 
of per capita spending on middle-aged adults. In 1963, this figure was 53 per- 
cent, and in 1970,64 percent. By 1977, per capita spending on infants was 97 
percent of spending on middle-aged adults. After  1977, spending on infants 
soared. By  1987, the average infant used 2.3 times the medical services that 
middle-aged adults did. Figure 4.1B shows relative spending plus or minus one 
standard error for 1963 and 1987. Given that there are relatively few infants in 
each survey year (200 to 500), it is not surprising that relative spending for 
infants is measured imprecisely. Still, the dollar amounts are staggering; real 
average spending for high-cost infants above the 90th percentile tripled in the 
1977-87  period, from $6,690 to $21,505. 
Figure 4.2  shows the implied growth rates of  spending. If  we define the 
“middle-aged” as those aged 1-64,  spending on the middle-aged rose 4.7 per- 
centage points per year between  1963 and  1987, while spending on infants 
rose by 9.8 percentage points per year. 
4. The current national health accounts tabulate spending by  payer and sector of  medical care 
provision (hospitals, physicians, etc.). For a set of  disease accounts for 1995, see Triplett (1997). 
5. The 1953 data are only available for more aggregated age groups: 0-5,  6-17,  18-24,  25-34, 
35-54.55-64.  and 65+. P 
4Yr  14  5-14  1524  25-34  35-44  45-54  55-64  65-74  75-84  85+ 
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Fig. 4.U  Age distribution of medical spending, 1953-87 
Note; The 1953 age groups are 0-5,6-17,  18-24,25-34,35-54,55-64,  and 65+. Relative spend- 
ing for 5-24-year-olds was constructed assuming a uniform age distribution. Dashed lines for 1953 
connect all age groups that were combined when calculating relative spending. 
(+  1963+-SE s 1987+-SEl 
Fig. 4.1B  Age distribution of medical spending (plus or minus one standard 
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1-64  B  65-74 
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Fig. 4.2  Growth of medical spending, 1963-87 
The change in relative spending for the elderly is equally dramatic but less 
concentrated in time. In 1953 and 1963, spending on the elderly was less than 
30 percent higher than spending on the middle-aged. In addition, among the 
elderly population, spending declined at increasingly  older ages during our 
sample period. Where the 75-84-year-olds  used  $689 per person  in  1963, 
those aged 85 or over used only $447 per person.  Over time, spending for 
the elderly has increased, particularly among the oldest old. By  1970, average 
spending on the elderly was twice the amount for 35-44-year-olds,  by  1977 it 
was 2.6 times, and by  1987 it was 4 times. Further, within the elderly popula- 
tion, spending on the population aged 85 and over increased even more dramat- 
ically than spending among the younger old. In  1963 per capita spending on 
those aged 85 or over equaled average spending on 35-44-year-olds.  By 1987, 
spending for the average person over age 85 was 5.2 times average spending 
for 35-44-year-olds.  As figure 4.2 shows, the growth of per person spending 
on the elderly averaged 8.0 percent annually between 1963 and 1987, includ- 
ing a rate of  over 10 percent annually for the oldest old. 
Recall that spending on the elderly excludes long-term care services, which 222  David M. Cutler and Ellen Meara 
have also increased over time; total medical spending has thus become even 
more skewed than these data suggest.h 
Figure 4.1A also shows a temporary  increase in spending on  15-24-year- 
olds in  1970 that is eliminated by  1977. In the  1970 sample, two young men 
aged 19 and 20 have unusually high charges, which causes average spending 
for this group to be skewed. 
The disproportionate growth of medical care spending for the elderly and 
the very young is substantively quite large. In  1963, spending on infants and 
the elderly accounted for 17 percent of total spending (1.6 percent for infants 
and 15.1 percent for the elderly). By  1987, spending on these two groups ac- 
counted for 36 percent of total spending (2.7 percent for infants and 33.2 per- 
cent for the elderly). We are not the first to document such a trend. Anderson 
et al. (1963) document a similar trend over the  1953-58  period. In the  1953 
and 1958 surveys, spending grew most rapidly for those under age 6 and those 
over age 65. Although the authors are unsure about the causes of  this rapid 
growth, they note that insurance enrollment grew more rapidly  for the aged 
than for others over this period. The trend of  rapid  spending growth for the 
young and the old has continued throughout our sample. 
As an alternative metric, figure 4.3 shows a simulation of medical spending 
if growth for the elderly and infants had matched growth for the middle-aged. 
The upper  line  graphs  actual per  capita medical  spending. The lower line 
graphs spending under the alternative scenario. By 1987, the disproportionate 
growth of  spending for infants and  the elderly  accounted for over $300  in 
spending per person, or over one-quarter of the total increase in medical spend- 
ing since 1953. 
Why has spending for infants and the elderly increased so rapidly? Has the 
increase been concentrated among high-cost  users or has it been spread more 
uniformly through the distribution? The views about wasteful  spending sug- 
gest that disproportionate  spending growth ought to be concentrated among 
the very high cost users in these groups. 
We address this question by considering aspects of the distribution of spend- 
ing broader than just the mean. Suppose we consider percentile q of the distri- 
bution of spending within each age group. That is, C;(a)  is spending at the qth 
percentile of age group u at time t. We can define relative spending at the qth 
percentile of the distribution as 
c: (a) 
qq(35-44). 
Crr."(a)  = 
Figure 4.4 shows relative spending at the 50th and 90th percentiles of  the 
spending distribution. For infants, neither the 50th nor the 90th percentile of 
6. Real spending on nursing homes has increased from $3.9 billion in 1960 to $41.9 billion in 
1985. Since 90 percent of nursing home residents are 65 years old or older, this implies that spend- 
ing has become even more skewed toward the elderly. 223  The Medical Costs of the Young  and Old: A Forty-Year Perspective 
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Fig. 4.3  Medical spending with less rapid cost growth for infants and elderly 
spending increases much relative to middle-aged adults. Even in 1987, the 90th 
percentile of spending for infants is only just above spending for 35-44-year- 
olds, while the mean was over two times higher. The implication is that essen- 
tially all of  the growth in spending occurs among the very high cost users- 
those  above  the  90th  percentile.  For the  elderly,  spending  for  the  median 
person  increases  substantially less than  spending for the mean  person,  and 
spending  at the  90th percentile  increases by  only the  amount of  the  mean. 
Thus, for the elderly as well there appears to be an increasing concentration of 
the distribution among high-cost users. 
We can be more precise about how much spending at different points in the 
distribution contributes to overall growth in spending. To do this, we first di- 
vide the sample into three age groups: under  1, or infants; 1-64,  or “middle- 
aged”; and 65 and older, or elderly. We then define “excess spending growth” 
as the increase in per capita spending resulting from more rapid  growth of 
spending for infants (or the elderly) than for the middle-aged population. In 
other words,  we ask the  question, What  would  spending on infants (or the 
elderly) be in 1987 if it grew at the same rate as spending on the middle-aged 
over the  1963-87  period? The difference between actual spending on infants 
(or the elderly) in 1987 and this hypothetical spending at middle-aged growth 
rates is total excess spending growth for an age group. Using infants as an ex- 
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(3)  Excess spending (< 1) = Spend,,,,(<  1) 
where Spend,(a) is average spending in age group a in year t. We then divide 
each age group into four subgroups: those in the bottom 50 percent  of the 
spending distribution, those in the 50th to 75th percentiles of  the spending 
distribution, those in the 75th to 90th percentiles of the distribution, and those 
above the 90th percentile. For each age group, we calculate what share of ex- 
cess spending is attributable to different parts of the spending distribution. 
Consider spending on the bottom 50 percent of the distribution. For infants, 
this is 
(4) 
where we have divided total spending in the bottom half of the distribution by 
the total number of infants N,(<1) so that this amount is the contribution of 
this set of infants to average spending. If  spending for the bottom 50 percent 
of the distribution had increased at the same rate as spending for the bottom 
50 percent of the middle-aged population, in 1987 this group would have spent 
S  pend:;;:  (1 -  64) 
Spendp;-,O(  1-64) 
(5)  Hypothetical Spend$::(<  1)  = Spendy;:,O(<  1) 
We  subtract  this  figure from Spend?;;:  and divide the result  by  total excess 
spending growth for infants to determine what share of excess spending growth 
for infants is attributable to infants in the bottom half of the distribution. 
Figure 4.5A  shows the contribution to excess spending growth for infants 
and the elderly made by faster growth in different parts of the distribution. In 
both cases, the excess growth in medical care spending is particularly concen- 
trated among high-cost users. For infants, 89 percent of the excess spending 
growth is a result  of  excess spending increases in the top  10 percent of  the 
population.’ For the elderly, 66 percent of excess spending growth results from 
higher cost growth in the top 10 percent of the distribution. 
The highly concentrated spending growth at the top of the distribution for 
infants and the elderly reflects concentrated spending growth on the very ill in 
all age groups. Figure 4.5B shows the annual percentage change in spending 
from 1963 to 1987 for different age groups and at different points in the spend- 
ing distribution within each age group. In all age groups, spending growth rises 
with percentile in the spending distribution. For those aged  1-64,  spending 
7. Indeed, 60 percent of spending growth is attributable to above average growth in the top 2 
percent of  the distribution. Because the number of infants is so small, however, the uncertainty 
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and elderly 
Accounting for excess medical spending growth among infants 
grew at an average rate of 4.7 percent per year, yet even at the 95th percentile, 
spending is growing more slowly, at 4.6 percent per year. This implies that 
as for infants and the elderly, spending growth for the middle-aged  is highly 
concentrated at the top of the distribution. However, spending growth is much 
slower for the middle-aged than for infants and the elderly, even above the 90th 
percentile of spending. 
An alternative  way  to examine whether our trends reflect rapid  spending 
growth for the ill of all ages is to choose a constant dollar amount and compare 
spending growth for all those who spend more than this amount. This allows 
us to look only at the most severely ill respondents in all age groups. Because 
the 1-64-year-old population is a healthier group than infants and the elderly, 
even those in the 95th percentile of  the distribution are likely to be relatively 
healthy and therefore spend little. We want to examine the tendency for spend- 
ing on the very ill at all ages to grow much more rapidly than per capita spend- 227  The Medical Costs of the Young and Old: A Forty-Year Perspective 
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Fig. 4.5B  Annual percentage change in spending by age group and percentile 
of spending, 1963-87 
ing in an age group. We looked at spending growth for those with real spending 
over  $2,000. Measured  in  1987 dollars, this  is  well  above 90th  percentile 
spending for all three groups in 1963 but below 90th percentile spending for 
all groups in 1987. Average spending for all infants spending over $2,000 grew 
7.8 percent annually between 1963 and  1987. The figure was 4.9 percent for 
the elderly and 2.4 percent for those aged 1-64.  The differences in growth rates 
among the very ill of  different ages show that, although the trend of  highly 
concentrated spending growth at the top of the spending distribution may occur 
within all age groups, it is most striking for infants and the elderly. 
It is thus clear that in understanding why medical care has become so con- 
centrated by  age, we need to understand why it has become so much more 
concentrated among high-cost users within any age. We turn to this next. 
4.3  Who Are the High-Cost Users? 
Understanding why high-cost users spend more than they used to is ham- 
pered by data problems. Only the 1977 and 1987 surveys contain detailed in- 
formation about diagnoses. Thus, we cannot look at the distribution of high- 
cost users over more than a 10-year period. Still, there was a substantial in- 
crease in concentration among high-cost users between  1977 and  1987, and 
we proceed with this analysis. 228  David M. Cutler and Ellen Meara 
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Fig. 4.6  High-cost elderly by primary diagnosis, 1987 
4.3.1  High-Cost Elderly 
We  begin with an analysis of the high-cost elderly. We  divide acute care 
spending and spending on prescription medicines for the elderly into 14 groups 
and one category for other diagnoses based on the chapters of the International 
Classijcation of  Diseases, 9th rev., as adapted for use in the Health Interview 
Survey (National Center for Health Statistics 1979). The categories include 
parasites and infections, neoplasms, endocrine, blood, mental disorders, cen- 
tral nervous system (CNS), circulatory system, respiratory system, digestive 
system, genitourinary system, skin, musculoskeletal system, injuries and poi- 
soning, impairments,  and other. Because the surveys use impairment  codes 
and often do not code congenital anomalies, we omit the congenital anomaly 
category and use the NMES category for impairments. Because we are focus- 
ing on those over age 65, conditions relating to pregnancy and the perinatal 
period are omitted. For each person, we sum all costs associated with each 
diagnosis group. We  then assign each person a "primary  diagnosis," or the 
diagnosis group that accounts for the largest amount of spending. In most cases 
(particularly for high-cost users), this is a fairly clear delineation. 
Figure 4.6 shows the distribution of primary diagnoses for the top 10 percent 
of elderly spenders in 1987. The most common diagnosis in this group is cir- 229  The Medical Costs of the Young and Old: A Forty-Year Perspective 
Table 4.2  Growth Rate of Costs for Primary Diagnosis of Circulatory 
Disorders or Neoplasms 
Average Spending" 
Annual Growth Rate of Real 












2,001  8,634 
(259)  (721) 
126  706 
(3  )  (49) 
449  5,171 
(11)  (155) 
2,443  15,203 
(103)  (493) 
14,546  46,593 
(2,045)  (3,579) 
Neoplasms 
5,552  8,590 
(611)  (946) 
492  788 
(56)  (54) 
4,232  5,610 
(401)  (298) 
10.689  15,657 
(438)  (595) 
25,079  43,886 











Note: Numbers in parentheses are standard errors. 
"Spending is in real (1987) dollars adjusted using the GDP deflator. 
culatory system disorders, accounting for 26.1 percent of the top spenders. 
Next in importance is other, then neoplasms (which includes benign and can- 
cerous growths), with 14.4  and 14.2 percent, respectively. The other diagnoses 
generally have 5 to 10 percent of the top spenders. 
The primary diagnoses of top spenders did not change substantially over the 
1977-87  period. In  1977, the  most  common  diagnosis was also circulatory 
system disorders (25.7 percent of  high cost users), followed by  other (1  1.4 
percent) and neoplasms (1  1.3 percent). We suspect, however, that if we were 
able to look at spending in the 1950s or 1960s, we would observe more change 
in primary diagnoses. 
We  examined growth in spending on circulatory disorders and cancers to 
see how it contributed to overall spending growth. We wanted to know whether 
costs grew more rapidly for these conditions than for overall spending. In ad- 
dition, we examined whether cost growth differed at different points in the 
spending distributions for these conditions. The top panel of table 4.2 shows 
growth in spending for individuals with a primary diagnosis of circulatory sys- 230  David M. Cutler and Ellen Meara 
tem disorder.8 Costs for the average patient with this primary diagnosis grew 
14.6 percent per year. This rapid growth occurred throughout the distribution 
of  spending on circulatory disorders, with growth in spending ranging from 
11.6 to 24.4 percent at different parts of the distribution. The bottom panel of 
table 4.2 shows a similar trend for patients with a primary diagnosis of neo- 
plasm.  Overall spending for patients with this primary diagnosis grew at an 
average annual rate of 4.4 percent. Growth was highest among the top 10 per- 
cent of  spenders with  a primary  diagnosis  of  neoplasm,  where real  growth 
averaged 5.6 percent per year. 
Since circulatory disorders were by far the most common primary diagnosis 
among the high-cost elderly, we examined them more closely by dividing cir- 
culatory disorder diagnoses into 16 detailed groups using the Clinical Classi- 
fications for Health Policy  Research (CCHPR). We were forced to collapse 
categories relating to ischemic heart disease into a single category and catego- 
ries relating to cerebrovascular disease into a single category because coding 
procedures used for the NMES did not distinguish between these groups. Table 
4.3 shows the individual CCHPR categories included under ischemic heart dis- 
ease and cerebrovascular disease. Figure 4.7 shows the distribution of detailed 
diagnoses for the high-cost elderly with a primary diagnosis of circulatory dis- 
order. Within this group, half had a diagnosis of ischemic heart disease in con- 
nection with their most expensive medical event. Cerebrovascular disease was 
diagnosed for 8.4 percent of the high-cost elderly during their most expensive 
medical event. In 1987, the average cost for an expensive medical event relat- 
ing to ischemic heart disease was $18,548 among the high-cost elderly. Cere- 
brovascular conditions were slightly less costly, averaging $16,566 for expen- 
sive medical events among the high-cost elderly. 
To gain a clearer picture of why these diseases are so costly, we looked at 
procedure codes in  1987. Unfortunately, most expensive medical events have 
no procedure codes. For the 30 percent  of  expensive events with procedure 
codes, the most common procedures are unspecified “other operations on ves- 
sels” occurring during 39.9 percent of these expensive medical events. “Other 
operations on heart and pericardium” and “operations on vessels of heart” are 
also common, occurring during 20.7 percent and 19.8  percent of coded expen- 
sive medical events, respectively. These procedure categories are broad, but 
they include bypass surgery, peripheral  bypass surgery, and other operations 
performed to treat ischemic heart disease. Not surprisingly, the procedures that 
make circulatory disorders expensive are operations to treat circulatory dis- 
eases, particularly ischemic heart disease and other vascular diseases. 
Using high-technology care to treat even common diagnoses contributes to 
8. The trends shown in table 4.2 do not change when one looks at all respondents with a circula- 
tory disorder instead of  limiting the sample to those with a primary diagnosis of  circulatory dis- 
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Table 4.3  Individual Diagnoses Included in Ischemic Heart and 
Cerebrovascular Diseases 
Diagnosis Groupd  CCHPR Recode" 
Ischemic heart disease  Acute myocardial infarction 
(heart attack) 
Coronary atherosclerosis 
(hardening of arteries) 
Other and ill-defined heart disease 
Cerebrovascular disease  Acute cerebrovascular disease 
Occlusion or stenosis of 
precerebral arteries 
Other and ill-defined 
cerebrovascular disease 
Transient cerebral ischemia 
Late effects of cerebrovascular 
disease 
Examples 
Postmyocardial infarction syndrome 
Intermediate coronary syndrome 
Old myocardial infarction 
Angina pectoris 
Other specified forms of chronic 
ischemic beart disease 
Aneurysm of heart 
Myocardial degeneration 
Cardiovascular disease, unspecified 
Cardiomegaly 
Rupture of chordae tendinae 
Rupture of papillary muscle 
Acquired cardiac septa1 defect 
Subarachnoid hemorrhage 
Intracerebral hemorrhage 
Other and unspecified intracranial 
hemorrhage 
Cerebral atherosclerosis 
Other generalized ischemic 
cerebrovascular disease 
Hypertensive encephalopathy 
Cerebral aneurysm, nonruptured 
Cerebral arteritis 
Moyamoya disease 
Nonpyogenic thrombosis of 
intracranial venous sinus 
Transient global amnesia 
"Used  in the 1987 National Medical Expenditure Survey. 
"Based on Clinical Classifications for Health Policy Research (CCHPR) recodes from the Agency for 
Health Care Policy and Research. 
the growth in relative spending for the elderly. For example, during the period 
1984-9 I, the share of Medicare patients with acute myocardial infarctions re- 
ceiving catheterization, angioplasty, bypass surgery, or some combination of 
these, grew from 11 percent to 41 percent (Cutler et al. 1996). The proliferation 
of  technology  to  treat  cardiovascular  disease probably  drives much  of  the 
spending growth for the high-cost elderly with circulatory disorders. 232  David M.  Cutler and Ellen Meara 
Fig. 4.7  Detailed diagnoses for high-cost elderly with primary diagnosis of 
circulatory disorder, 1987 
4.3.2  High-Cost Infants 
Understanding the reasons for increased spending among high-cost infants 
is more difficult than it is for the high-cost elderly. Generally, the surveys omit 
diagnosis codes for infants, and procedure codes are rarely used. This makes 
it impossible  for us to use the  “primary  diagnosis”  approach to  understand 
high-cost users. Nor does the survey contain information such as birth weight 
of the infant or subsequent infant death. 
However, the survey does provide some clues about what makes high-cost 
infants different from other infants. Sixty percent of high-cost infants experi- 
enced their most expensive medical event at the time of birth. It is much rarer 
for postbirth medical problems to lead to high spending. Two-thirds of high- 
cost infants did not undergo any surgery during their most expensive medical 
event. 
Perhaps most striking is how long high-cost infants were in the hospital. The 
average length of stay for high-cost infants during their most expensive medi- 
cal event was 23 nights in 1987.  That was a dramatic increase over 1977, when 
high-cost infants stayed in the hospital only 13 nights during their most expen- 
sive stay. 
Indeed, figure 4.8 shows the distribution of lengths of  stay for all infants at 
the time of birth. Although the share of births requiring one-night or zero-night 
stays increased in 1987 compared with 1977, the upper tail of the distribution 
also increased in 1987 compared to 1977. For example, only 1 percent of births 
in 1977 were in the hospital over 30 days, compared to 6 percent in 1987. 
The reason for a long stay at birth is generally complications related to pre- 233  The Medical Costs of the Young and Old: A Forty-Year Perspective 
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Fig. 4.8  Length of stay at time of birth, 1977-87 
mature delivery. Infants born very prematurely tend to have respiratory or other 
developmental problems that either result in immediate death or require long 
hospital stays. Over time, as the technology available to treat these infants has 
improved, more of them may be surviving premature birth but requiring longer 
hospital stays. 
This is consistent with the sketchy evidence that is available on the diagnosis 
of high-cost infants. Fifty-seven percent of high-cost episodes had a diagnosis 
code. Of these events, 24 percent had a condition code indicating that the baby 
was born prematurely-between  1,000 and 2,400 grams at birth. Among ba- 
bies who were not high cost, less than 1 percent have a diagnosis code indicat- 
ing that they were born prematurely. 
The most common conditions among high-cost  infants were disorders in- 
volving the respiratory system. Thirty-five percent of the high-cost sample had 
a respiratory condition in connection with their most expensive medical event. 
These ranged  from  postbirth  respiratory  disease to  congenital  respiratory 
anomalies and a variety of lower respiratory diseases. Respiratory conditions 
(pneumonia excepted) are a frequent complication of premature birth. 
The evidence  seems consistent  with a story of increasing  costs related to 
low birth weight. As technology to treat premature babies has improved, the 
costs of  low-birth-weight  children-and  thus the overall costs of  infants- 
have increased. 
Historical trends in the proliferation of neonatal care support this contention. 
In particular,  the increasing cost of infants after the mid-1970s  is consistent 234  David M. Cutler and Ellen Meara 
with the major technological innovation of this period-the  diffusion of neo- 
natal intensive care units (NICUs). NICUs are intensive care facilities specially 
designed for complications arising shortly after birth, such as respiratory fail- 
ure or incomplete physical development. In  1976, the first year that the Ameri- 
can Hospital Association  kept data on this technology, 8 percent of hospitals 
had an NICU, and there were 5,630 NICU beds in total. By  1990, 19 percent 
of hospitals had an NICU, and the number of NICU beds had nearly d~ubled.~ 
Among the largest hospitals (those with 400 or more beds), two-thirds had an 
NICU in 1990. 
Although we cannot be certain with our data, we suspect that the diffusion 
of NICUs and their associated technologies explains much of the cost explo- 
sion for infants. Medical technology is buying us, in the crudest sense, care for 
infants who previously died at birth. 
4.4  The Value of Medical Spending 
Understanding the sources of cost growth is only one concern; determining 
the value of this spending is a second. In this section, we look at crude mea- 
sures of outcomes to see whether there is some contemporaneous relation be- 
tween spending increases and health. We do not interpret these data as causal. 
Instead, we are interested in examining whether the basic facts about health 
outcomes are consistent with the cost trends. If increased spending on cardio- 
vascular disease and neoplasms in the elderly is not associated with better out- 
comes for patients with these diseases in the aggregate, it will be hard to argue 
that medical spending is buying much in the way of improved health. In future 
work, we intend to examine the causality issue in more detail. 
4.4.1  The Health of the Elderly 
Given that over 40 percent of the high-cost elderly have primary diagnoses 
relating to circulatory disorders or malignant neoplasms, one can look to mor- 
tality rates for these diseases for evidence on how outcomes for patients with 
these diseases have changed over time. 
Figure 4.9 shows death rates for four groups of diagnoses: diseases of the 
heart, cerebrovascular disease, malignant neoplasms, and all other diagnoses. 
Over the three decades between 1960 and 1990, death rates for heart disease 
and cerebrovascular disease have plummeted. In 1960, the age-adjusted death 
rate due to heart disease was 287 per  100,000. This figure fell by nearly half, 
to 152 per 100,000, by  1990. Similarly, deaths due to cerebrovascular disease 
fell by 60 percent, from 80 per  100,000 in  1960 to 28 per  100,000 in  1990. 
This is certainly consistent with improved, but high-cost, medical care. 
9. In both of  these years, the number of NICUs is slightly understated because hospitals that 
had neonatal intensive care services as part of their medicalhrgical ICU were not counted. The 
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Fig. 4.9  Changes in death rates for high-cost diagnoses, 1960-90 
Source: National Center for Health Statistics, Trends in  the Health of  Older Americans: United 
States, 1994 (Hyattsville, Md.,  1994). 
In contrast to the improvements in outcomes for major circulatory diseases, 
deaths attributable to malignant neoplasms followed a slow but steady rising 
trend during this period, with deaths per 100,000  rising from 125 to 135.  While 
mortality due to neoplasm has declined for younger ages, mortality rates have 
increased for those over age 50 (Cohen and Van Nostrand 1995). Similar trends 
in cancer mortality have been documented in Canada (Berkel 1995). Clearly, 
we have made little progress in preventing death from cancer over this period. 
Of course, the technologies that have increased costs may not have been the 
ones that extended life. The source of  reduced  mortality for cardiovascular 
disease is the subject of  great debate. The general consensus in the literature 
(Hunink et al. 1997) is that high-tech medicine has been less important in im- 
proved health than have been lifestyle modifications and pharmaceuticals that 
provide better primary prevention (reduced incidence of  disease at all) and 
secondary  prevention  (reduced  incidence  of  disease reoccurrence).  But  the 
contributions of these different factors are likely to change over time, and there 
has been much less analysis of the reasons for improved health over the past 
decade than in previous periods. 
4.4.2  The Health of Infants 
The most readily available measure of health outcomes for infants is infant 
mortality; we consider what has happened to mortality in the first year of life 
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Fig. 4.10  Infant mortality by birth weight, 1960-91 
Sources: National Center for Health Statistics, “A Study of Infant Mortality from Linked Records 
by Birth Weight, Period of Gestation and Other Variables: United States, 1960 Live Birth Cohort” 
(Rockville, Md., 1972);  National Center for Health Statistics, Health: United States 1995 (Hyatts- 
ville, Md., 1972). 
ever, we examine infant mortality by birth weight. There are two reasons for 
this. First, to the extent that technological  changes are concentrated  among 
premature infants, mortality reductions  should be concentrated in this group 
as well. In addition, exogenous changes in birth weights for infants will natu- 
rally affect infant mortality, and we want to purge these from our estimates. 
Figure 4.10 shows infant mortality rates (deaths per 1,000 live births) in the 
years  1960, 1983, and  1991. Over the period  1960-91,  dramatic gains were 
made in mortality outcomes for low-birth-weight babies, particularly those un- 
der 2,000 grams. Among babies born between  1,500 and 1,999 grams, deaths 
per 1,000 dropped 75 percent, from 207 to 40. Among the 1,000-1,499  gram 
babies, deaths per  1,000 dropped by  80 percent, from 549 to 91, over these 
three decades. Among those born under 1,000 grams, deaths per 1,000 fell by 
half, from 919 to 521. 
In Figure 4.11 we show the annual percentage decline in infant mortality by 
birth weight from 1960 to 1983 and from 1983 to 1991. The most prominent 
feature in this graph is the way the decline in infant deaths occurs most rapidly 
in the low-birth-weight ranges, particularly  in the 1,000-1,999  gram range. 
This is especially pronounced  for the  1983-91  period. From  1960 to  1983, 
infant mortality reductions  were greater among lighter infants but not by  a 
large amount. The decline was about 5.5 percent per year for the lighter infants 237  The Medical Costs of the Young and Old: A Forty-Year Perspective 
._ 
< 1,000  1.000-1,499  1,500-1,999  2,000-2,499  2,500-2.999  3,0004499  3,500-3,999  4.000-4.499  4.500 8 up 
Birth Weight (grams) 
(u~%ace1i60-83i~tniaIoA  Decrease 1983.91 I 
Fig. 4.11 
Sources: National Center for Health Statistics, “A Study of Infant Mortality from Linked Records 
by Birth Weight, Period of Gestation and Other Variables: United States, 1960 Live Birth Cohort” 
(Rockville, Md.,  1972); National Center for Health Statistics, Heulfh: (Inired Srures 1995 (Hyatts- 
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Decline in infant mortality by birth weight, 1960-91 
and perhaps 4  percent per year for the normal-birth-weight infants. After 1983, 
however, infant mortality reductions were particularly concentrated among the 
lightest infants. Mortality for infants born between 1,000 and 1,499 grams, for 
example, declined by  7 percent per year, compared to 3 percent per year for 
normal-birth-weight infants. 
The increasing emphasis on mortality reductions for the lightest infants over 
the  1980s is consistent with the diffusion of medical care designed for very 
low birth weight infants. Recall that the costs of  very expensive infant care 
increased most rapidly from the late 1970s to the late 1980s and that NICUs 
expanded most rapidly in this period. Thus, the evidence is certainly consistent 
with a fair return to medical spending. 
The one exception to this story is the very lightest group-those  born under 
1,000 grams. For these infants, reductions in mortality have been low in all 
periods. We  suspect that one reason we do not observe such rapid improve- 
ments in infant mortality for babies born under  1,000 grams is the way  live 
births were counted. Although nothing changed in the official definition of live 
births over the 1960-91 period, it is plausible that very premature infants who 
died minutes after birth were  not counted as live births when there was no 
technology available to treat them. Now that technology offers more possibili- 238  David M. Cutler and Ellen Meara 
ties for saving very low birth weight babies, these babies are more likely to be 
counted as live births so that the number of  live births has increased  in  low- 
birth-weight ranges.'" 
Some evidence for this is provided by the increasing number of  very  low 
birth  weight live births over time. The ratio of  births below  1,000 grams to 
births between  1,000 and 1,499 grams has been increasing over time, even as 
the ratio of births between 1,000 and 1,499 grams and 1,500 and 1,999 grams 
has been relatively constant. 
One drawback of using infant mortality to measure gains in infant health is 
that it provides  no evidence about long-term outcomes for low-birth-weight 
babies. There is considerable evidence that low-birth-weight babies who sur- 
vive the neonatal  period are much more likely  than  heavier  infants to have 
problems that continue throughout childhood and later in life (Institute of Med- 
icine  1985; Saigal et al. 1996). The evidence presented here does not capture 
this component, which should be included in any evaluation of the costs and 
benefits of increased medical spending on infants. 
4.5  Conclusions 
Although growth and concentration in health care spending have been well 
documented, until now we have known little about the nature of this growth 
and the high-cost spenders that drive it. Our analysis shows a striking trend in 
the growth of  health care spending. Not only is spending at a point in time 
highly concentrated at the top of the spending distribution, but growth in health 
care spending is highly concentrated as well. We find that growth is most rapid 
among the young, those less than I year old, and the old, those 65 years old or 
older. Within these rapid growth groups, increased spending is largely driven 
by  those at the top of the  spending distribution. We  find that 89 percent  of 
excess  spending  growth  for  infants  originates  from tremendous  growth  in 
health care spending for the top  10 percent  of the  spending distribution of 
infants. For the elderly, 66 percent of excess spending growth originates from 
high-cost users. Among the young, this spending often is associated with birth, 
and a connection with premature birth seems likely. Among the old, circulatory 
disorders and neoplasms are the most common primary, or high-cost, diag- 
noses. 
In our initial attempts to see whether gains in health outcomes are consistent 
with increased spending, we find that high spending growth on a particular 
population or condition is accompanied by gains in health outcomes for these 
conditions over time. While overall infant mortality has plummeted since 1960, 
the reductions are largest among low-birth-weight babies. In our analysis of 
diseases driving high-cost elderly spending, we find that deaths due to circula- 
10. Across types of  medical care, diagnosis of  a disease is strongly associated with ability to 
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tory  disorders have decreased dramatically  over time,  even during periods 
when mortality due to other causes is relatively constant. The trend in mortality 
for malignant neoplasms is an exception to the broad finding that where spend- 
ing is most concentrated gains in health outcomes are great. Future research 
should try to determine whether the correlation between high spending and 
health gains is causal. Regardless of whether this relationship is causal, our 
findings suggest that one can understand more about the growth in health care 
spending by learning more about technologies aimed at helping very ill infants 
and elderly. 
Our results also have implications for forecasting medical spending growth 
over time. Common forecasts of medical spending do not account for changes 
in relative spending by age over time. Our results suggest that this understates 
the future growth of costs, since the fastest growing age group, the population 
aged 85 and over, is also the group whose costs are growing most rapidly. 
Finally, determining what caused the shift in resources toward infants and 
the elderly is important. Clearly, the advent of Medicare and Medicaid and the 
increased generosity of private health insurance coverage have played a role in 
raising the share of medical spending on infants and the elderly. However, little 
is known about the mechanism that transforms increased insurance coverage 
into technological improvements, and ultimately gains in health. Answering 
these questions should be part of any agenda to contribute to debates on medi- 
cal spending. Appendix 
Table 4A.1  Average Spending by Age Group 1963-87 
Average Annual  Average Annual 
Percentage Change  Percentage Change 
Age Group  1953,'  1963  I970  I977  1987  1953-87  1963-1987 
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Notes; Average spending is in real (1987) dollars using the GDP deflator. Numbers in parentheses are standard errors. 
'The  1953 age groups are 0-5,  6-17,  18-24,  25-34,  35-54,55-64,  and 65 +  . Average spending for 5-24-year-olds  was constructed assuming a uniform age distri- 
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ComrIlent  David Meltzer 
This paper examines the distribution of medical care costs among and within 
age groups over a 40-year period in order to try to better understand why medi- 
cal care has become so expensive over time and what its value to society has 
been. It comes to three basic conclusions: 
1. Costs have increased disproportionately for the young and the very old. 
2. Most of these costs are associated with “technically” intensive aspects of 
medicine-the  care of premature babies and adults with cardiovascular disease 
or cancer. 
3. With respect to the value of these treatments, there is some evidence that 
mortality has decreased in the areas where expenditures have increased. 
The first part of  the paper makes two basic points. The first is that costs 
have increased disproportionately for the very young and old compared to the 
“middle-aged” (ages 1-64!). The second is that essentially all of the dispropor- 
tionate growth in spending on the very young and old is accounted for by  high- 
cost users in those groups. 
These are important facts and may suggest where we will need to look if we 
are to control health care costs. Nevertheless, it seems possible that the two 
points may really be condensed into just one: that health care expenditures in 
all age groups have risen because of a few high-cost users. The growth in costs 
among the middle-aged may be relatively smaller because there may be pro- 
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portionately  fewer very  sick people  in  the middle-aged  group-yet  just as 
much rapid growth in costs among those who are very sick. It is hard to distin- 
guish these two possibilities from the paper because all the results are normal- 
ized relative to that middle group. 
This suggests that it would be useful to break down spending at each point 
in  time  by  age group and  percentile  within each age group then  trace the 
growth in these amounts over time. This procedure  would describe, for ex- 
ample, the annual percentage growth in expenditures for the 90th percentile of 
middle-aged individuals-a  rate that is hidden by the normalization in the cur- 
rent calculations. These numbers could be reported either in per capita terms 
or as total spending for the age group. If reported as changes in total spending, 
the changes could then be decomposed into changes in the numbers of people 
in the age group and changes in per capita expenditures conditional on age and 
percentile in the spending distribution within that age group. 
I suspect that this would show that the sickest middle-aged people have also 
had extremely fast growth in costs. Such a finding could help provide some 
further insight into why spending among middle-aged people has grown less 
quickly than spending among the very young and old. One possibility is that 
we have increased our aggressiveness in treating the very young and old. How- 
ever, it is equally plausible that, if a smaller percentage of middle-aged people 
tend to be sick than of the very young or the elderly, a given percentile among 
the middle-aged will be healthier than the same percentile among the other age 
groups. The middle-aged group would thus be less likely to have rapid growth 
in costs if most cost growth is among the very sick. Examination of the growth 
of  expenditures among the highest percentiles across these age groups might 
help distinguish these hypotheses. 
This also suggests that it may be useful to analyze cost growth across the 
life cycle over time by examining the percentage of costs due to people with 
costs above some level in real terms (e.g., $1,000 in  1994 dollars). Another 
approach would be to look at growth in the costs of treating specific conditions 
arising at different ages-for  example, heart attacks at ages 40,50,60,70,  and 
so on. The comparison would then change from an age-normalized  one to an 
objective one not affected by the relative health of others of the same age. 
With appropriate longitudinal data, one could then begin to trace out lifetime 
costs. This could be particularly useful in instances where changes in expendi- 
tures lead to changes in survival that, in turn, induce future expenditures. Some 
of the work I have done on future costs in medical cost-effectiveness analysis 
suggests that these costs may be nontrivial (Meltzer 1997). Future costs such 
as these might imply that the costs associated with an intervention performed 
in a particular age group could appear in other age groups. This could provide 
some insight into why costs have increased so greatly among the very sick by 
separating changes in survival from technical change, changes in prices, and 
other causes of increased health care costs. 
The second part of the paper examines particular diagnoses for these high- 244  David M. Cutler and Ellen Meara 
cost users: heart  disease and cancer for the old  and premature birth  for the 
young. There are no surprises here; these diagnoses are well recognized to be 
the most common causes of serious illness in these age groups. Of course, it is 
worth remembering that these conditions may be to some extent acute manifes- 
tations of chronic conditions. For example, heart disease may result from dia- 
betes, or premature birth may result from maternal substance abuse. This fact 
is important because it is a reminder that the most effective and efficient way 
to decrease the costs of caring for the extremely ill may, in some cases, be pre- 
vention. 
The third part of paper shows that mortality has tended to decrease in those 
areas where costs have increased. The authors are careful not to say that this 
relationship is causal, but the motivation is clearly to suggest that medical ex- 
penditures in these areas may be of value. I suspect that this is correct but agree 
with the authors that other interpretations are possible. Expenditures may have 
increased because mortality has decreased. For example, imagine that we ob- 
serve decreased cardiovascular mortality at the same time that costs increase. 
It could be that high spending to save patients from heart attacks leads to de- 
creased mortality. On the other hand, it could also be that the accidental discov- 
ery of an inexpensive intervention that saves lives (e.g., administration of an 
aspirin in the emergency room to a patient with chest pain) also leads to pro- 
longation of life and years of interventions with questionable value at the mar- 
gin (e.g., cardiac catheterizations and treatment for congestive heart failure). 
To take another example, cancer can sometimes cause elevations in the amount 
of calcium in the blood (hypercalcemia) and can sometimes present itself first 
with the symptoms of hypercalcemia. Hypercalcemia can be fatal in the ab- 
sence of good treatments, but effective and fairly inexpensive treatments are 
now available. The consequence, however, could be that people with cancer 
survive long enough to receive chemotherapy and incur the high costs associ- 
ated with it. Even if chemotherapy had no effect on survival, we could observe 
that chemotherapy expenditures increase at the same time that cancer mortality 
decreases, but there would be no causal connection between the two, and most 
of the expenditures would be wasted. 
Still, it seems likely that health care expenditures on the seriously ill have 
often had substantial payoffs. The vast body of literature from randomized clin- 
ical trials suggests that there is value in a wide range of medical interventions. 
The question  is ultimately  not whether medical  interventions  have had any 
value in improving health, but the magnitude of their contributions compared 
to other causes of  improving  health,  such as expenditures on public  health 
and increases in income and education. With respect to tuberculosis,  there is 
evidence that the largest decreases in the burden of disease resulted from im- 
provements in nutrition and public health that occurred before the development 
of effective treatments (McKeown 1988). With respect to cardiovascular mor- 
tality, older work suggested that treatment might not have been as important as 
prevention  in reducing mortality, but some of the newest work suggests that 
more recent trends have been more heavily influenced by high-tech  interven- 245  The Medical Costs of the Young and Old: A Forty-Year Perspective 
tions. For example, a recent study suggests that more than three-fourths of the 
increase in survival after heart attacks in Minneapolis in the 1980s was due to 
acute interventions (McGovern et al. 1996). Of course, this is survival after a 
heart attack, and prevention may have a much bigger overall effect on cardio- 
vascular mortality than does treatment. With cancer death rates not declining 
for the most part, it is hard to argue that huge strides have been made in that 
area (Bailar 1997). Certainly, it is possible that we would have done better with 
an emphasis on prevention  and  screening rather than an emphasis on acute 
treatment. 
As a brief aside about the relatively slow decline in death rates for very low 
birth weight babies, it is worth noting that, while this could reflect changes in 
definitions of live versus still births, as suggested by the authors, it could also 
reflect the fact that existing technology is often simply not able help these in- 
fants. 
I would like to make two last points about the implications of this research. 
First, the fact that health care costs are highly concentrated among high-cost 
users and are remaining so over time suggests that cost containment will have 
to come by controlling costs among this group. To the extent that this is accom- 
plished  through  changes in the financing and organization of  health care as 
opposed to cost-reducing medical technologies, it is likely to be difficult with- 
out managed care or prospective payment for inpatient care because most de- 
ductibles in traditional insurance are too small to be relevant for these sorts of 
large expenditures. One possible exception is medical savings accounts with 
very high deductibles. These arrangements might be effective, but there are 
still many questions concerning their intertemporal aspects as well as their 
effects on adverse selection. This may be somewhat less true to the extent that 
decreases in outpatient coverage can decrease inpatient utilization as suggested 
by the RAND Health Insurance Experiment (Manning et al.  1987). However, 
the RAND experiment lasted only a relatively short time, and it is quite pos- 
sible that policies that try to lower expenditures by limiting outpatient expendi- 
tures would backfire by increasing preventable illness and hospitalization over 
the long run. 
The second point is that patterns and trends in health care expenditures over 
the past 40 years may or may not be a good guide to the future. The increas- 
ingly popular view of health care as part of wellness-ranging  from prevention 
to sports medicine-could  cause much more growth in costs to occur among 
the well than among the severely ill. That seems unlikely, however. 
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